Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Current Deferred Revenue (2017 - 2018)

Historic Current Deferred Revenue for Sanara MedTech (SMTI) over the last 2 years, with Q4 2018 value amounting to $10474.0.

  • Sanara MedTech's Current Deferred Revenue fell 2475.57% to $10474.0 in Q4 2018 from the same period last year, while for Dec 2018 it was $10474.0, marking a year-over-year decrease of 2475.57%. This contributed to the annual value of $10474.0 for FY2018, which is 2475.57% down from last year.
  • Per Sanara MedTech's latest filing, its Current Deferred Revenue stood at $10474.0 for Q4 2018, which was down 2475.57% from $12141.0 recorded in Q3 2018.
  • Over the past 5 years, Sanara MedTech's Current Deferred Revenue peaked at $13920.0 during Q4 2017, and registered a low of $10474.0 during Q4 2018.